The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

but the extent of these reviews are still uncertain. New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria. Now, they want to determine whether it can be combined with other antibiotic ...

Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer’s disease, offering hope for slowing its progression. These laboratory-produced molecules are designed to ...

The results can inform a doctor if a person has an elevated level of thyroglobulin antibodies, which could indicate autoimmune diseases or cancer. This article reviews the TgAb test, what to ...

Collaboration builds on Alloy’s existing and highly productive engagement with Pfizer and will apply Alloy’s innovation expertise to address Pfizer’s specific ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.